genscript biotech corporation

Supporting Safe And Efficient Work With cPass™ Testing

GenScript’s cPass serology test helped one construction firm, AcroMeta Group, ensure employees could make informed decisions on their individual COVID-19 risk and prevention.

GenScript Launches Manufacturing Facility In Singapore

GenScript’s new facility is set to improve support for scientists in the Asia-Pacific region with shorter delivery time and local collaboration.

Singapore Develops COVID-19 Kit That Detects Neutralizing Antibodies

The cPass kit, which is the first of its kind in the world, can detect neutralizing antibodies against SARS-CoV-2 in an hour.